NCT04230083View on ClinicalTrials.gov

Bioavailability of Dienogest 2.0 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 7, 2019

Primary Completion Date

December 10, 2019

Study Completion Date

December 24, 2019

Conditions
Bioequivalence
Interventions
DRUG

Dienogest 2.0 mg Test Drug

Bioequivalence

DRUG

Dienogest 2.0 mg Reference Product

Bioequivalence

Trial Locations (1)

7510491

Innolab, Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT04230083 - Bioavailability of Dienogest 2.0 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter